9.1.4. Platelet Disorders
Click Here for Kent and Medway Health Economy National Tariff Excluded Drugs Manual -High Cost Drugs
|
|
This High-Cost Drug has been approved for the following indications: - Treatment of primary chronic immune thrombocytopenia (ITP) refractory to other treatments (for example, corticosteroids, immunoglobulins) in adults. |
| Avatrombopag for treating primary chronic immune thrombocytopenia NICE TA853 |
Avatrombopag (Doptelet)|
|
This High-Cost Drug has been approved for the following indications: - Treatment of chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments. |
| For more information and NICE Guidance Click Here | Fostamatinib for treating refractory chronic immune thrombocytopenia NICE TA835 |
- First Line Choice
- On Formulary
- Specialist Initiation Only
- Hospital Only
- KMPT Initiation Only